
Baculovirus Expression Vector System
Applications
Working Volume Scale 500-Liter
The BEVS has been used to produce recombinant proteins for research use and drug screening for a significant period of time. The development of human pharmaceutical products has broadened dramatically in the last decade in the following areas:
Vaccines - Infectious Diseases
- Influenza (Seasonal & Pandemic)
- Human Papilloma Virus
- Emerging Pathogens (i.e. SARS)
- Biodefense Vaccines (i.e. Ebola)
Vaccines/Immunotherapies
- Oncology (Prostate and Breast Cancer)
- Diabetes
Gene Therapy - rAAV (recombinant adeno-associated virus)
- Muscular Dystrophy
- Genetically-based Lipid Disorders (i.e. Lipoprotein Lipase Deficiency)
- CNS Disorders (Alzheimer's, Parkinson's)
Biologics
- Growth Factors (Wound Healing)
- Antivirals (rAAV - Hepatitis C)
- Anti-inflammatory Diseases/Arthritis (rAAV)


